funding probability score
total disclosed funding
last round valuation estimate
disclosed funding rounds
latest round
latest funding stage
next round estimate
development stage
number of investors
number of competitors
monthly web visits
twitter followers
United States
HQ address
6400 Westwind Way, Crestwood, 40014, USA
Apellis Pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (COPD), diseases of the retina such as age-related macular degeneration (AMD), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (PNH). Apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. We call this approach Complement Immunotherapy.

There is much more to this profile.
Log in or sign up for free to see the whole thing.

Get free access to these powerful tools:
- Advanced search filters
- Full startup and investor profiles
- Follow startups and investors
- Custom follow-lists
- Startup benchmarking
- Network maps
- Market stats